Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.

OCAT

Ocata Therapeutics, Inc. (OCAT)

(MM)
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:OCAT
DataHoraFonteTítuloCódigoCompanhia
22/02/201615:44Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:OCAT(MM)
16/02/201617:55Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:OCAT(MM)
12/02/201614:32Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:OCAT(MM)
11/02/201619:39Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OCAT(MM)
11/02/201616:12Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:OCAT(MM)
10/02/201619:34Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:OCAT(MM)
10/02/201619:24Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:OCAT(MM)
10/02/201612:48PR Newswire (US)Astellas Announces Results of Tender Offer to Acquire All Outstanding Shares of Ocata Therapeutics and Changes to Subsidiarie...NASDAQ:OCAT(MM)
10/02/201612:21Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OCAT(MM)
10/02/201612:21Edgar (US Regulatory)(25-NSE)NASDAQ:OCAT(MM)
10/02/201612:18Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:OCAT(MM)
10/02/201612:03Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:OCAT(MM)
22/01/201611:52PR Newswire (US)Astellas Extends Tender Offer to Acquire All Outstanding Shares of Ocata TherapeuticsNASDAQ:OCAT(MM)
06/01/201619:05Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:OCAT(MM)
28/12/201511:00Business WireOcata Reports the Publication of Data about the Generation of Corneal Endothelial Cells from Human Pluripotent Stem CellsNASDAQ:OCAT(MM)
04/12/201519:03The Motley FoolOcata Therapeutics Almost Doubled in November -- Here's WhyNASDAQ:OCAT(MM)
03/12/201511:30Business WireOcata’s Hemangio-derived Mesenchymal Cells Preserve Kidney Function & Extend Lifespan in Preclinical Model of Lupus NephritisNASDAQ:OCAT(MM)
24/11/201519:38PR Newswire (US)Harwood Feffer LLP Announces Investigation of Ocata Therapeutics, Inc.NASDAQ:OCAT(MM)
19/11/201519:13Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:OCAT(MM)
19/11/201517:28Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:OCAT(MM)
12/11/201519:09Business WireOCATA SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces the Investigation of Ocata Therapeutics, Inc. (OCAT) Over the Propos...NASDAQ:OCAT(MM)
11/11/201516:09Business WireOCATA THERAPEUTICS, INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe & Powers Taylor LLP Investigate Merger with As...NASDAQ:OCAT(MM)
10/11/201521:23PR Newswire (US)SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Ocata Therapeutics, Inc. of Commencement of an Investigatio...NASDAQ:OCAT(MM)
10/11/201519:32Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:OCAT(MM)
10/11/201518:27Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:OCAT(MM)
10/11/201518:03Business WireSHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Ocata Therapeutics, Inc. And Encourages ...NASDAQ:OCAT(MM)
10/11/201514:55Business WireINVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Ocata Therapeutics, Inc. of Commencement of an Investigation I...NASDAQ:OCAT(MM)
10/11/201501:05PR Newswire (US)Astellas to Acquire Ocata TherapeuticsNASDAQ:OCAT(MM)
09/11/201511:03Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:OCAT(MM)
06/11/201519:52Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:OCAT(MM)
 Apresentando as notícias mais relevantes sobre:NASDAQ:OCAT